Athira Pharma GAAP EPS of -$0.80 misses by $0.27
· seekingalpha.com
Athira Pharma (LONA) Q2 GAAP EPS -$0.80 missed by $0.27; cash fell to $51.1M and burn rose to $37.9M.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...